In three patients mutations in other ARVC-associated genes (DSC2 /ACMG-VUS/, DSG2 /ACMG-pathogenic/, and DSP /ACMG-VUS/) were found—these patients were classified as PKP2 mutation negative. This evidence concerns the gene DSC2 and arrhythmogenic right ventricular cardiomyopathy.